Aspen Aerogels (NYSE:ASPN) Reaches New 12-Month Low - Should You Sell?

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) hit a new 52-week low during trading on Friday . The stock traded as low as $6.60 and last traded at $6.79, with a volume of 285036 shares. The stock had previously closed at $6.93.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. B. Riley reduced their price objective on shares of Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a research note on Wednesday, February 19th. Barclays decreased their target price on shares of Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 19th. TD Cowen raised shares of Aspen Aerogels to a "strong-buy" rating in a report on Tuesday, March 11th. Seaport Res Ptn downgraded shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 12th. Finally, StockNews.com raised Aspen Aerogels to a "sell" rating in a research note on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, one has given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Aspen Aerogels currently has an average rating of "Moderate Buy" and a consensus price target of $19.11.

Remove Ads

Aspen Aerogels Stock Performance

The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The firm has a market cap of $588.69 million, a P/E ratio of 44.82 and a beta of 2.28. The business has a fifty day simple moving average of $9.39 and a 200-day simple moving average of $14.99.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, sell-side analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Institutional Trading of Aspen Aerogels

Several hedge funds and other institutional investors have recently made changes to their positions in ASPN. Quest Partners LLC boosted its holdings in Aspen Aerogels by 263.3% in the third quarter. Quest Partners LLC now owns 7,397 shares of the construction company's stock worth $205,000 after acquiring an additional 5,361 shares in the last quarter. Sandia Investment Management LP purchased a new position in shares of Aspen Aerogels in the 4th quarter worth about $89,000. Kovitz Investment Group Partners LLC bought a new position in Aspen Aerogels in the 3rd quarter worth about $263,000. Morse Asset Management Inc bought a new position in Aspen Aerogels in the 3rd quarter worth about $264,000. Finally, Wealth Enhancement Advisory Services LLC purchased a new stake in Aspen Aerogels during the 4th quarter valued at about $129,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.